A new weight loss drug has been approved for use in the UK, offering patients a new treatment option.

Eli Lilly provides early access to an innovative weight loss drug for patients, offering hope before formal FDA approval.

FDA approval of a new narcolepsy drug opens doors for an entirely new class of effective treatments.

Takeda's approval marks the beginning of a new wave of sleep disorder medications that will help millions of patients.

FDA approval of a new narcolepsy drug opens doors for an entirely new class of treatments.

A new highly effective 'Triple G' weight loss drug offers patients a promising treatment option.

Karyopharm advances selinexor combination therapy toward FDA approval for myelofibrosis under expedited review.

FDA approves a fast-acting non-opioid pain relief medication combining Tylenol and Naproxen, offering patients safer pain management alternatives.

A clinical trial demonstrates excellent safety results for kidney disease patients with anemia, offering hope for a new treatment option.

Outlook Therapeutics gains FDA approval for a new AMD drug, providing patients with additional treatment options.

A newly FDA-approved ADHD medication offers patients a different approach to treatment.

A pharmaceutical company secures significant funding following FDA approval of an innovative new treatment.

FDA approval of eye disease drug expands treatment options for patients with vision-threatening conditions.

New initiatives are addressing critical gaps in blood disorder treatment, research, and patient support.

New hope emerges with a potential treatment for the deadly Ebola strain affecting the DRC.

China approves innovative drug ciprocopan succinate as a new treatment option for patients with paroxysmal nocturnal hemoglobinuria.

A new treatment for anemia in kidney patients has demonstrated safety success in clinical trials.

China approves a new narcolepsy drug, expanding treatment options for patients with this sleep disorder.

A new focal therapy technique has proven highly effective at treating prostate cancer with patients remaining cancer-free a decade later.

A new breakthrough offers hope for healing previously intractable lung diseases.

FDA approval of a new cholesterol pill expands treatment options for patients.

A new cholesterol-fighting drug approval provides additional treatment options for patients.

Real-world safety data confirms the approved ALS drug continues to be well-tolerated in patients.

Q32's alopecia drug study succeeded, offering hope to millions suffering from hair loss.

Futura Medical's Eroxon treatment and WSD4000 device represent advances in addressing sexual health conditions.

A medical breakthrough significantly improves a patient's quality of life and health outcomes.

Two boys with rare Hunter syndrome find hope and healing through a new FDA-approved treatment.

Palvella Therapeutics advances toward FDA approval for QTORIN™, a potential new treatment for microcystic lymphatic malformations.

FDA approval of a new psoriasis treatment for children as young as 2 years old offers families a new therapeutic option for this chronic condition.

Viridian has received FDA approval for Lumvoa, a new treatment offering patients additional therapeutic options.

First medicine approved under new 'fast access' procedure, accelerating patient access to needed treatments.

FDA clears an investigational remyelinating agent for multiple sclerosis treatment.

A weight-loss drug has been approved by Health Canada that can help treat sleep apnea, offering patients a new therapeutic option.

A new drug helps preserve muscle health in patients using GLP-1 weight-loss treatments, improving quality of life.

A patient given just three years to live in 1998 has thrived for over two decades, offering hope to others.

A new diabetes drug approved by the NHS is heralding a transformative new era in diabetes treatment.

The FDA has approved Moderna's innovative mRNA-based flu vaccine, expanding protection against seasonal influenza.

A newly approved species of fly offers an innovative biological approach to wound healing and treatment.

Regeneron's drug application for cemdisiran is accepted for FDA and EMA review, advancing treatment options for patients.

A groundbreaking Parkinson's disease treatment is transforming patients' lives with lasting improvements.

A new antibiotic treatment for complicated urinary tract infections has received FDA approval.

UniQure is moving forward with a promising gene therapy for Huntington's disease after FDA alignment.

Aethlon Medical's Hemopurifier advances through final trial stages offering hope for critically ill patients.

FDA accepts a new drug application for cenobamate oral suspension, advancing seizure disorder treatment.

FDA acceptance of Gilead's new drug application represents progress toward bringing a new therapeutic option to patients.

FDA approves a new treatment option for kidney cancer patients at risk of recurrence.

Belite Bio advances toward FDA approval for an oral therapy treating Stargardt disease, a previously untreatable retinal condition.

Lupus patients achieve remission through pioneering gene therapy trial, offering life-changing hope for autoimmune disease sufferers.

Weight-loss drug Wegovy becomes available in pill form in the UK, expanding patient access.

Emergency FDA approval brings screwworm treatment to pets in need.

FDA approval of Ebglyss provides patients with a new eczema treatment option.

More cancer patients are living longer as targeted drug therapies continue to improve survival rates.

Wisconsin epilepsy research could help patients achieve seizure-free lives.

FDA approval of a new orally disintegrating tablet formulation offers patients greater treatment flexibility for chronic myeloid leukemia.

InnoCare's new drug application acceptance marks progress toward bringing a new treatment to patients.

FDA approves Hepcludex as the first-ever treatment for hepatitis D, offering hope to patients with limited options.

A new targeted cancer therapy receives priority review status, accelerating its path to patients in need.

A father celebrates his son's ability to access a new life-changing drug, bringing hope to families.

FDA approval of an innovative kidney stone treatment developed through biomedical engineering offers patients a new solution.